Indications
Prevention of deep venous thrombosis in patients undergoing elective hip or knee replacement surgery.
Composition
- Active substance
- desirudin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Revasc
- Active substance
- desirudin
- ATC code
- B01AE01
- Therapeutic area
- Venous Thrombosis
- Marketing authorisation holder
- Canyon Pharmaceuticals Ltd.
- Status
- Withdrawn
- EU authorisation
- 9 Jul 1997
- Withdrawn
- 18 Jul 2014